Home / Health / UK Trial Explores Inulin's Role in Reducing Cancer Treatment Side Effects
UK Trial Explores Inulin's Role in Reducing Cancer Treatment Side Effects
17 Jun
Summary
- A new trial is testing inulin supplements for prostate cancer patients.
- Inulin may help reduce side effects from radiotherapy treatment.
- The DIETRICH trial will recruit 220 men from eight UK cancer centers.
The DIETRICH trial, a new study conducted across eight UK cancer centers, is exploring the effectiveness of inulin supplements for men receiving radiotherapy for prostate cancer. This dietary intervention aims to mitigate significant side effects commonly experienced by patients. Early evidence indicates that inulin may help reduce issues like erectile dysfunction and radiotherapy proctitis.
Approximately 220 men are expected to participate in the trial. Half will receive inulin enrichment, while the other half will take a placebo. Researchers are optimistic that this study could significantly improve the lives of prostate cancer patients by reducing treatment-related side effects.
Prostate cancer is the most common cancer in the UK, highlighting the importance of comprehensive patient support. This trial focuses not only on cancer treatment but also on ensuring patients lead comfortable lives after their treatment concludes.
